Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.

Animals Aristolochic Acids / toxicity Carcinogenesis / chemically induced Carcinogens / toxicity DNA Adducts / metabolism DNA, Neoplasm / metabolism Male Rats Rats, Wistar
Balkan endemic nephropathy DNA adducts NAD(P)H:quinone oxidoreductase 1 aristolochic acid I aristolochic acid II aristolochic acid nephropathy aristolochic acid-mediated carcinogenesis cytochrome P450 genotoxicity

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Sep 2021
Historique:
received: 22 08 2021
revised: 20 09 2021
accepted: 23 09 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 27 10 2021
Statut: epublish

Résumé

The plant extract aristolochic acid (AA), containing aristolochic acids I (AAI) and II (AAII) as major components, causes aristolochic acid nephropathy (AAN) and Balkan endemic nephropathy (BEN), unique renal diseases associated with upper urothelial cancer. Recently (Chemical Research in Toxicology 33(11), 2804-2818, 2020), we showed that the

Identifiants

DOI: 10.3390/ijms221910479 PMID: 34638820 PMC: PMC8509051
pubmed: 34638820
pii: ijms221910479
doi: 10.3390/ijms221910479
pmc: PMC8509051
pii:
doi:

Substances chimiques

Aristolochic Acids 0
Carcinogens 0
DNA Adducts 0
DNA, Neoplasm 0
aristolochic acid B 0
aristolochic acid I 94218WFP5T

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Grantová Agentura České Republiky
ID : 18-10251S

Références

Oncotarget. 2016 Jul 19;7(29):45225-45236
pubmed: 27286260
Cancer Res. 1996 May 1;56(9):2025-8
pubmed: 8616845
Arch Toxicol. 2015 Jan;89(1):47-56
pubmed: 24792323
Environ Mol Mutagen. 2013 Jan;54(1):1-7
pubmed: 23238808
Chem Res Toxicol. 1991 Sep-Oct;4(5):581-6
pubmed: 1665354
Biochim Biophys Acta. 2011 Jan;1814(1):132-8
pubmed: 20624491
Int J Mol Sci. 2014 Jun 10;15(6):10271-95
pubmed: 24918288
Neuro Endocrinol Lett. 2008 Oct;29(5):733-7
pubmed: 18987598
Int J Cancer. 2005 Sep 20;116(5):667-78
pubmed: 15828049
Mutat Res. 2008 Jan-Feb;658(1-2):55-67
pubmed: 17851120
Neuro Endocrinol Lett. 2012;33 Suppl 3:25-32
pubmed: 23353840
Drug Metab Rev. 1997 Feb-May;29(1-2):413-580
pubmed: 9187528
Int J Cancer. 2016 Feb 15;138(4):976-82
pubmed: 26335255
Carcinogenesis. 1997 May;18(5):1063-7
pubmed: 9163697
PLoS Biol. 2011 Dec;9(12):e1001222
pubmed: 22205878
Drug Metab Dispos. 2006 Nov;34(11):1803-5
pubmed: 16896062
Nat Prod Rep. 2003 Dec;20(6):565-83
pubmed: 14700200
Arch Biochem Biophys. 2010 Sep 1;501(1):116-23
pubmed: 20361926
Carcinogenesis. 1990 Feb;11(2):313-9
pubmed: 2302759
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12129-34
pubmed: 17620607
Pharmacol Rep. 2011;63(6):1491-9
pubmed: 22358097
Biochem J. 2004 Jan 1;377(Pt 1):205-13
pubmed: 14510636
Xenobiotica. 1994 Dec;24(12):1151-75
pubmed: 7771104
Genes Environ. 2015 Jul 30;37:11
pubmed: 27350808
Mutat Res. 2001 Jun 27;493(1-2):149-60
pubmed: 11516724
Am J Kidney Dis. 2004 Apr;43(4):e11-7
pubmed: 15042566
Mutagenesis. 2020 Sep 12;35(4):349-358
pubmed: 32608486
Biochem Pharmacol. 1994 Aug 30;48(5):923-36
pubmed: 8093105
Kidney Int. 2008 Jun;73(11):1231-9
pubmed: 18368031
Chem Res Toxicol. 2013 Feb 18;26(2):290-9
pubmed: 23289503
Environ Mol Mutagen. 2012 Oct;53(8):636-41
pubmed: 22987305
Semin Nephrol. 2019 May;39(3):284-296
pubmed: 31054628
Int J Cancer. 2002 Oct 10;101(5):500-2
pubmed: 12216081
Toxicol In Vitro. 2011 Jun;25(4):810-6
pubmed: 21300145
Int J Mol Sci. 2015 Nov 18;16(11):27561-75
pubmed: 26593908
Mutagenesis. 2015 Nov;30(6):763-70
pubmed: 26443852
Mutagenesis. 2014 May;29(3):189-200
pubmed: 24598128
J Ethnopharmacol. 2009 Aug 17;125(1):108-44
pubmed: 19505558
Kidney Int. 2008 Jun;73(11):1209-11
pubmed: 18480852
Neuro Endocrinol Lett. 2011;32 Suppl 1:57-70
pubmed: 22167209
Toxicol Sci. 2011 Aug;122(2):288-96
pubmed: 21613233
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8241-6
pubmed: 22493262
Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1600-1608
pubmed: 27555084
Nat Commun. 2020 May 1;11(1):2169
pubmed: 32358516
Drug Metab Dispos. 2000 Sep;28(9):1063-8
pubmed: 10950850
Cancer Res. 2003 Jun 1;63(11):2752-61
pubmed: 12782579
J Nat Prod. 2016 Jan 22;79(1):30-7
pubmed: 26706944
PLoS One. 2016 Oct 7;11(10):e0164215
pubmed: 27716846
Sci Transl Med. 2013 Aug 7;5(197):197ra102
pubmed: 23926200
Chem Biol Interact. 2000 Dec 1;129(1-2):77-97
pubmed: 11154736
Toxicol Appl Pharmacol. 2012 Dec 15;265(3):360-7
pubmed: 22982977
Biochem Pharmacol. 2002 Mar 1;63(5):889-96
pubmed: 11911841
Carcinogenesis. 1988 Feb;9(2):297-303
pubmed: 3338114
Carcinogenesis. 2002 Apr;23(4):617-25
pubmed: 11960915
Free Radic Biol Med. 2000 Aug;29(3-4):254-62
pubmed: 11035254
Gen Physiol Biophys. 2001 Dec;20(4):375-92
pubmed: 11989648
Arch Toxicol. 2015 Nov;89(11):2141-58
pubmed: 25209566
Int J Mol Sci. 2016 Feb 05;17(2):213
pubmed: 26861298
Monatsh Chem. 2017;148(11):1971-1981
pubmed: 29104318
BMC Urol. 2019 Apr 18;19(1):24
pubmed: 30999871
Toxicol Sci. 2011 May;121(1):43-56
pubmed: 21362632
Cancer Res. 2002 Oct 15;62(20):5678-84
pubmed: 12384524
Korean J Intern Med. 2018 Sep;33(5):961-969
pubmed: 29551056
Chem Res Toxicol. 2015 Nov 16;28(11):2130-41
pubmed: 26473469
Chem Res Toxicol. 2011 Oct 17;24(10):1710-9
pubmed: 21932800
Int J Cancer. 2018 Oct 1;143(7):1578-1587
pubmed: 29667191
Cell. 2019 May 2;177(4):821-836.e16
pubmed: 30982602
Food Chem Toxicol. 2008 Mar;46(3):1157-63
pubmed: 18164532
Drug Metab Dispos. 2010 May;38(5):761-8
pubmed: 20164109
Carcinogenesis. 2003 Oct;24(10):1695-703
pubmed: 12869422
Carcinogenesis. 2007 Nov;28(11):2253-61
pubmed: 17434925
Chem Res Toxicol. 2003 Jan;16(1):38-47
pubmed: 12693029
Kidney Int. 2008 Jul;74(2):158-69
pubmed: 18418355
Methods Mol Biol. 2013;1044:389-401
pubmed: 23896889
Neuro Endocrinol Lett. 2011;32 Suppl 1:121-30
pubmed: 22167220
Curr Drug Metab. 2013 Jul;14(6):695-705
pubmed: 23701164
Arch Toxicol. 2019 Sep;93(9):2689-2701
pubmed: 31451845
Xenobiotica. 2012 Aug;42(8):731-6
pubmed: 22360448
Drug Metab Rev. 2004 Oct;36(3-4):639-54
pubmed: 15554240
Arch Toxicol. 2017 Apr;91(4):1957-1975
pubmed: 27557898
Crit Rev Toxicol. 1995;25(1):25-65
pubmed: 7734059
Mutat Res. 2012 Mar 18;743(1-2):52-8
pubmed: 22245565
Nephrol Dial Transplant. 2008 Oct;23(10):3074-81
pubmed: 18495746
Int J Cancer. 2005 Jan 10;113(2):189-97
pubmed: 15386410
Genome Med. 2015 Apr 28;7(1):38
pubmed: 26015808
Toxicology. 2016 Feb 17;344-346:7-18
pubmed: 26845733
Toxicol Sci. 2012 Feb;125(2):345-58
pubmed: 22086975
Sci Transl Med. 2013 Aug 7;5(197):197ra101
pubmed: 23926199
Int J Urol. 2020 Apr;27(4):327-332
pubmed: 32100370
Arch Toxicol. 2016 Nov;90(11):2595-2615
pubmed: 27538407
N Engl J Med. 2000 Jun 8;342(23):1686-92
pubmed: 10841870
Mutat Res. 2001 Jul 25;494(1-2):143-50
pubmed: 11423353
Kidney Int. 2012 Mar;81(6):559-67
pubmed: 22071594
Biopharm Drug Dispos. 2011 Nov;32(8):482-7
pubmed: 21968795
Carcinogenesis. 1997 May;18(5):1055-62
pubmed: 9163696
Mutat Res Genet Toxicol Environ Mutagen. 2014 Jul 1;768:1-7
pubmed: 24769487
Mutagenesis. 2002 Jul;17(4):265-77
pubmed: 12110620
Arch Biochem Biophys. 2013 Sep 1;537(1):31-8
pubmed: 23800876
Arch Toxicol. 2019 Nov;93(11):3345-3366
pubmed: 31602497
Carcinogenesis. 1994 Jun;15(6):1187-92
pubmed: 8020154
Ann Intern Med. 2013 Mar 19;158(6):469-77
pubmed: 23552405
Chem Res Toxicol. 2001 Aug;14(8):1128-37
pubmed: 11511187
Int J Cancer. 2014 Jul 15;135(2):502-7
pubmed: 24921086
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt A):1-401
pubmed: 23189749
Onco Targets Ther. 2017 Dec 05;10:5775-5782
pubmed: 29255365
Chem Res Toxicol. 2020 Nov 16;33(11):2804-2818
pubmed: 32894017
Drug Metab Dispos. 2007 Jul;35(7):1217-22
pubmed: 17392392
Xenobiotica. 2014 Jan;44(2):135-45
pubmed: 24152141

Auteurs

František Bárta (F)

Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40 Prague 2, Czech Republic.

Alena Dedíková (A)

Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40 Prague 2, Czech Republic.

Michaela Bebová (M)

Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40 Prague 2, Czech Republic.

Šárka Dušková (Š)

Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42 Prague 10, Czech Republic.

Jaroslav Mráz (J)

Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42 Prague 10, Czech Republic.

Heinz H Schmeiser (HH)

Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Volker M Arlt (VM)

Department of Analytical, Environmental and Forensic Sciences Division, King's College London, 150 Stamford Street, London SE1 9NH, UK.
Toxicology Department, GAB Consulting GmbH, Heinrich-Fuchs-Str. 96, 69126 Heidelberg, Germany.

Petr Hodek (P)

Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40 Prague 2, Czech Republic.

Marie Stiborová (M)

Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40 Prague 2, Czech Republic.
ORCID: 0000-0001-5430-4403

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Co-Exposure to Aristolochic Acids I and II...
questionsmedicales.fr › Composés polycycliques › Hydrocarbures aromatiques polycycliques › Phénanthrènes › Acides aristolochiques › Co-Exposure to Aristolochic Acids I and II...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Carcinogenèse › Co-Exposure to Aristolochic Acids I and II...
questionsmedicales.fr › Actions chimiques et utilisations › Actions toxiques › Noxas › Cancérogènes › Co-Exposure to Aristolochic Acids I and II...
questionsmedicales.fr › Phénomènes génétiques › Altération de l'ADN › Adduits à l'ADN › Co-Exposure to Aristolochic Acids I and II...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ADN › ADN tumoral › Co-Exposure to Aristolochic Acids I and II...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Co-Exposure to Aristolochic Acids I and II...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Rat Wistar › Co-Exposure to Aristolochic Acids I and II...